clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Coronavirus
Mini Lungs Reveal More Cells Susceptible to COVID-19
News & Features
Antimicrobial Susceptibility Test Turnaround Time Slashed by Novel Method
News & Features
New Therapeutic Target Found for Acute Myeloid Leukemia
News & Features
Fecal Microbiota Transplants Could Boost Cancer Immunotherapy Efficacy
News & Features
New Research Shows Potential for Ketone Therapy in Heart Failure
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition
Agilent
Molecular Dx
Agilent Revs up Precision Medicine Push with Planned Resolution Bioscience Acquisition
Alex Philippidis
-
March 3, 2021
0
Molecular Dx
Agilent and Visiopharm Plan to Merge Resources to Market Complimentary Cancer Diagnosis Technology
Christina Jackson
-
March 4, 2020
0
News & Features
Top 10 Sequencing Companies
Alex Philippidis
-
April 8, 2019
0
Molecular Dx
Cancer Dx Developer Burning Rock Completes $125.5M Series C Round
Inside Precision Medicine Staff Writer
-
February 14, 2019
0
Molecular Dx
Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer
Inside Precision Medicine Staff Writer
-
June 13, 2018
0
News & Features
Integrated Metabolic Analysis and Imaging Platform
Inside Precision Medicine Staff Writer
-
May 10, 2018
0
Molecular Dx
Top 10 Sequencing Companies
Inside Precision Medicine Staff Writer
-
April 9, 2018
0
Molecular Dx
Agilent Buys Lasergen for $105M, Two Years after Taking 48% Stake
Inside Precision Medicine Staff Writer
-
April 5, 2018
0
News & Features
ASHG Day 2 News Digest: Fabric Genomics, Edico Genome, Agilent, Invitae, and More
Inside Precision Medicine Staff Writer
-
October 19, 2017
0
News & Features
Agilent Wins Expanded Use in Europe for Opdivo Diagnostic in Urothelial Cancer
Inside Precision Medicine Staff Writer
-
June 16, 2017
0
1
2
Page 1 of 2
Related Content
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Ultra-Rare Disorders Diagnosed with New Routine Healthcare Framework
Correct AI Diagnoses May Have Hidden Flaws
AI-Human Interaction Could Aid Pancreatic Cancer Diagnosis
Inside Precision Medicine
![Agilent Technologies’ Dako PD-L1 IHC 22C3 pharmDx assay has become the first FDA-approved companion diagnostic to identify patients with cervical cancer for treatment with Merck & Co.'s cancer immunotherapy Keytruda (pembrolizumab). [Agilent Technologies]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1724-768x218.jpeg "Agilent CDx for Keytruda Gets FDA Approval for Cervical Cancer")
![Agilent Technologies has won expanded use for its Dako PD-L1 IHC 28-8 pharmDx test in Europe for patients with urothelial cancer who are mosty likely to benefit from treatment with Opdivo.[Agilent Technologies]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1133.jpeg "Agilent Wins Expanded Use in Europe for Opdivo Diagnostic in Urothelial Cancer")
